Intermountain Medical Center names Blair Kent as new administrator

The flagship campus of Intermountain Healthcare will now be led by Blair Kent, MPA, the hospital system announced on May 17.

Kent’s move to the 504-bed Intermountain Medical Center in Murray, Utah comes after more than 25 years of experience within the health system. Holding titles such as business manager and regional operations officer, he moved into his first administration role at Intermountain’s then-newly built Riverton Hospital in 2008. He added the roles of CEO and administrator at the system’s Alta View Hospital in Sandy, Utah, in 2016.

“Blair is a very effective leader and is well prepared for this position,” said Joe Mott, MBA, associate chief operating officer of specialty-based Care at Intermountain Healthcare and Kent’s predecessor as administrator. “He’s forward thinking and is enthusiastic about Intermountain Medical Center’s vision to be one the premier hospitals in the nation and model referral center for hospitals and patients throughout the Intermountain West.”

Kent isn’t a stranger to the flagship hospital—the largest medical campus in Utah—as he helped in its planning and opening in 2007 in his role as an operations officer.

“I loved the hospital and its people when I served there previously, and I’m excited to work with our hospital team to support Intermountain’s efforts to deliver the best possible care as efficiently as possible and to enhance not just the healthcare, but the health and the lives of our employees, physicians, and all the patients and families that we serve,” Kent said.

Kent holds a master’s degree in public administration from Brigham Young University and a bachelor’s in health services administration from Weber State University.

Intermountain Medical Center was recognized as the second-best hospital in Utah by U.S. News and World Report in 2017, as well as being ranked No. 48 nationally in pulmonology and named as a high-performing hospital in nephrology, urology, cancer and diabetes care.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.